The Paediatric Regulation has “basically forced” companies to tailor drugs for use by children, but more work is needed to plug gaps in the area of childhood rare diseases
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.